Butler, William
McDowell, Colin http://orcid.org/0000-0001-8739-277X
Yang, Qing http://orcid.org/0000-0003-4844-4690
He, Yiping
Zhao, Yue http://orcid.org/0000-0002-0110-0359
Hauck, J. Spencer
Zhou, Yinglu http://orcid.org/0000-0001-6276-635X
Zhang, Hong
Armstrong, Andrew J. http://orcid.org/0000-0001-7012-1754
George, Daniel J. http://orcid.org/0000-0002-0836-8542
Drake, Richard http://orcid.org/0000-0002-6285-6440
Huang, Jiaoti http://orcid.org/0000-0003-1195-1998
Funding for this research was provided by:
Prostate Cancer Foundation
Article History
Received: 6 July 2022
Accepted: 13 February 2023
First Online: 24 February 2023
Competing interests
: J.H. is a consultant for or owns shares in the following companies: Amgen, Artera, Kingmed Diagnostics, Teddy Clinical Research Laboratories, MoreHealth, OptraScan, Genetron, York Biotechnology, Genecode, VIVA Biotech, Seagen Inc. and Sisu Pharma. J.H. has received research support/grants from Zenith Epigenetics, BioXcel Therapeutics, Inc., Dracen Pharmaceuticals and Fortis Therapeutics. A.J.A. is a consultant or advisor for the following companies: Astellas, Epic Sciences, Pfizer, Bayer, Janssen, Dendreon, BMS, AstraZeneca, Merck, Forma, Celgene, Clovis, Exact Sciences, Myovant, Exelixis, GoodRx, and Novartis. A.J.A. has received research support/grants from NIH/NCI, PCF/Movember, DOD, Astellas, Pfizer, Bayer, Janssen, Dendreon, BMS, Astrazeneca, Merck, Forma, Celgene, Amgen, and Novartis. D.J.G. is a consultant for, or has personal/financial interests in, the following companies: Advanced Accelerator Applications SA/Novartis, American Association for Cancer Research, Astellas, Astrazeneca, AVEO Pharmaceuticals, Bayer H/C Pharmaceuticals, BMS, Calithera, Eisai, Exelixis, IdeoOncology, Janssen, MedScape Education, Merck Sharpe & Dohme, Michael J Hennessey Associates, Leidos Biomedical Research Inc, Novartis, Pfizer, Propella TX, RevHealth, Sanofi, Seattle Genetics, UroGPO, UroToday, WebMD, WilmerHale Attorneys, and Xcures. The remaining authors declare no competing interests.